← Oncology Approval Tracker

FDA DECISION ·

Epkinly

epcoritamab-bysp · Genmab US

FDA approvalNew or expanded indicationFollicular lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma.

LAMPGEN ANALYSIS

Why it matters

EPCORE FL-1 supported a bispecific combination for an earlier relapsed setting than the monotherapy label.

What research teams should watch

Implement the combination-specific step-up calendar and prepare for cytokine release syndrome, neurotoxicity, infection, and cytopenia monitoring.

PRIMARY RECORDS

Sources